Welcome to the European Gynecologic Oncology Congress
As new therapies revolutionize the treatments and outcomes of ovarian,
cervical, and endometrial cancers, it is becoming increasingly difficult
to determine the optimal therapy for these devastating diseases.
Oncology specialists require access to the most current, meaningful,
and concise information on the use of the novel agents used in the
treatment of these diseases, as well as guidance from the experts as to
how to provide optimal therapy to patients.
We are pleased to invite you to this meeting and we are looking forward to your participation.
